Latest News and Press Releases
Want to stay updated on the latest news?
-
Ottawa, Nov. 03, 2025 (GLOBE NEWSWIRE) -- The global organoids market size was valued at USD 69.90 million in 2024 and is predicted to hit around USD 381.7 million by 2034, rising at a 18.5% CAGR, a...
-
HOUSTON, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) is collaborating with Spanios on a non-clinical study using New Alternate Methodologies (NAM)-based...
-
Pluristyx and Solesis partner to launch game-changing standardized organoid kits, powered by iPSC and polymer technologies.
-
Pluristyx & BioLamina partner to accelerate iPSC-based therapies with integrated cell culture solutions, for consistency, scalability & clinical success.
-
New York, USA, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Global Organoids Market to Surge Significantly at a CAGR of ~14% by 2030 | DelveInsight The demand for organoids is being driven mainly by an...
-
Pune, India, Sept. 01, 2023 (GLOBE NEWSWIRE) -- An organoid is a miniaturized and simplified version of an organ fabricated in vitro in three dimensions that mimics the essential functional,...
-
Pune, India., June 01, 2023 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Organoids Market Size Report, Share, Revenue, Growth Strategy, Industry Trends and Forecast...
-
Selbyville, Delaware, May 17, 2023 (GLOBE NEWSWIRE) -- 3D Cell Culture Market size is estimated to reach USD 5.5 billion by 2032, according to a new research report by Global Market Insights...
-
NEW YORK, April 26, 2023 (GLOBE NEWSWIRE) -- Rumi Scientific (“Rumi”), a developer of therapies for rare and neurodegenerative diseases discovered using its high throughput organoid phenotypic...
-
NEW YORK, March 30, 2023 (GLOBE NEWSWIRE) -- Rumi Scientific (“Rumi”), a developer of therapies for rare and neurodegenerative diseases discovered using its high throughput organoid phenotypic...